Get started
Author

F Krause

Observed names: F S Krause, F. Krause, F. S. Krause, F. St. Krause, F.S. Krause, Krause, Fedor:
OpenAlex ID: A5110069682
Radiochemotherapy for Bladder Cancer
2009 · O.J. Ott, C. Rödel, et al. · Clinical Oncology · 44
Neuropilin-2 and its ligand VEGF-C predict treatment response after transurethral resection and radiochemotherapy in bladder cancer patients
2014 · B. Keck, S. Wach, et al. · International Journal of Cancer · 41
PDF
Micropapillary morphology is an indicator of poor prognosis in patients with urothelial carcinoma treated with transurethral resection and radiochemotherapy
2016 · Simone Bertz, S. Wach, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 33
Radiochemotherapy after transurethral resection is an effective treatment method in T1G3 bladder cancer.
2005 · Z Akçetin, J Todorov, et al. · PubMed · 7
Does the distance to normal renal parenchyma (DTNRP) in nephron-sparing surgery for renal cell carcinoma have an effect on survival?
2005 · Z Akçetin, V Zugor, et al. · PubMed · 6
Polymorphisms of human estrogen receptor (ER) gene alpha and beta in prostate cancer PC-EW and PC-OR cell lines.
2007 · C C Bergner, F S Krause, et al. · PubMed · 5
The Photodynamic Diagnosis (PDD) for Early Detection of Carcinoma and Dysplasia of the Bladder
2003 · A. Zumbraegel, K.-H. Bichler, et al. · Springer eBooks · 5
Lungenagenesie und ösophageale Nebenlunge
1972 · J. Dortenmann, F. Krause, et al. · The Thoracic and Cardiovascular Surgeon · 2
Validation of a trimodalitiy treatment and selective organ preservation for bladder cancer: Influence of clinical different parameters on the 15-year long-term outcome.
2010 · F. Krause, O. Ott, et al. · Journal of Clinical Oncology · 1
B-Zell-Lymphome des Hodens
2006 · V. Zugor, M. Frank, et al. · Der Urologe · 1
201 Evaluation of plasmatic Kisspeptin as a biomarker for malignancy and subtype differentiation in small renal tumours
2015 · M. Horstmann, F. Krause, et al. · European Urology Supplements
785 Neuropilin-2 and VEGF-C are independent prognostic factors for bladder cancer patients treated with transurethral resection and radiochemotherapy
2014 · B. Keck, S. Wach, et al. · European Urology Supplements
11 Validation of Clinical Parameters on the 15-year Long-term Outcome of a Trimodalitiy Treatment and Selective Organ Preservation for Invasive Bladder Cancer
2010 · F.S. Krause, O. Ott, et al. · European Urology Supplements
Untitled
2009 · Krause, Fedor: · DMW - Deutsche Medizinische Wochenschrift
Serotonin Used as Prognostic Marker of Urological Tumours
2008 · F.S. Krause, B. Wullich · European Urology Supplements
Management of Superfical Recurrence After Complete Response to Combined Modality Treatment in Bladder Cancer
2007 · C. Weiss, D.G. Engehausen, et al. · International Journal of Radiation Oncology*Biology*Physics
Validity of DNA-methylation marker PITX2 to predict risk of recurrence in lymph node-negative hormone receptor-positive breast cancer patients: a transfer study.
2005 · C Markert-Hahn, Samira Jaeger, et al. · mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich)
[Local treatment of infections in the thoracic area].
1979 · F Krause · PubMed
[Long-term results of surgery of bronchogenic squamous cell carcinoma (author's transl)].
1977 · F Krause · PubMed
[Indications for surgical pulmonary biopsy].
1976 · H Wörner, F Krause · PubMed
[Diagnosis and therapy of traumatic diaphragmatic hernia].
1972 · R Bähr, R Wenzel, et al. · PubMed
Zur Diagnostik der traumatischen Milzruptur bei Mehrfachverletzungen
1971 · R. Wenzel, R. Bähr, et al. · DMW - Deutsche Medizinische Wochenschrift
[Improvement of cancer therapy of the abdominal organs].
1971 · F Krause · PubMed
[Significance of rectal polyps in general practice].
1970 · R Wenzel, R Bähr, et al. · PubMed
[Echinococcosis in the region of the urogenital system].
1966 · K M Bauer, F Krause · PubMed
Works count: 25
Citation count: 145
H-index: 5
I10-index: 3
Year
Topic
Type